- call +1-201-465-4211
- email sales@mrinsights.biz
Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).
Scope of the Report:
This report studies the Macular Edema Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Macular Edema Therapeutics market by product type and applications/end industries.
The market of macular edema is dominated by North America which is followed by Europe due tremendous number of population suffering from diabetics. Asia Pacific region have also shown faster rate of increases of macular edema therapeutics market. While Africa and Australia have low market of Macular edema. In Asia pacific region India, China and Brazil have shown emerging growth in the global market of macular edema therapeutics.
The global Macular Edema Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Macular Edema Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Allergan
Novartis
Roche
Regeneron Pharmaceuticals
Pfizer
Bayer
Boehringer Ingelheim
Bausch & Lomb
Aciont
ActiveSite Pharmaceuticals
Adverum Biotechnologies
Aerpio Therapeutics
Ampio Pharmaceuticals
Araim Pharmaceuticals
Astellas Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Laser Treatment
Anti-VEGF Injection
Anti-Inflammatory Treatment
Vitrectomy
Market Segment by Applications, can be divided into
Cystoid Macular Edema (CME)
Diabetic Macular Edema(DME)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Macular Edema Therapeutics Market Overview
1.1 Product Overview and Scope of Macular Edema Therapeutics
1.2 Classification of Macular Edema Therapeutics by Types
1.2.1 Global Macular Edema Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Macular Edema Therapeutics Revenue Market Share by Types in 2017
1.2.3 Laser Treatment
1.2.4 Anti-VEGF Injection
1.2.5 Anti-Inflammatory Treatment
1.2.6 Vitrectomy
1.3 Global Macular Edema Therapeutics Market by Application
1.3.1 Global Macular Edema Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Cystoid Macular Edema (CME)
1.3.3 Diabetic Macular Edema(DME)
1.4 Global Macular Edema Therapeutics Market by Regions
1.4.1 Global Macular Edema Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Macular Edema Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Macular Edema Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Macular Edema Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Macular Edema Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Macular Edema Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Macular Edema Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Macular Edema Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Macular Edema Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche
2.3.1 Business Overview
2.3.2 Macular Edema Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Regeneron Pharmaceuticals
2.4.1 Business Overview
2.4.2 Macular Edema Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Regeneron Pharmaceuticals Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Macular Edema Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Macular Edema Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Boehringer Ingelheim
2.7.1 Business Overview
2.7.2 Macular Edema Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Boehringer Ingelheim Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bausch & Lomb
2.8.1 Business Overview
2.8.2 Macular Edema Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bausch & Lomb Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aciont
2.9.1 Business Overview
2.9.2 Macular Edema Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aciont Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 ActiveSite Pharmaceuticals
2.10.1 Business Overview
2.10.2 Macular Edema Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 ActiveSite Pharmaceuticals Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Adverum Biotechnologies
2.11.1 Business Overview
2.11.2 Macular Edema Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Adverum Biotechnologies Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.12 Aerpio Therapeutics
2.12.1 Business Overview
2.12.2 Macular Edema Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Aerpio Therapeutics Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.13 Ampio Pharmaceuticals
2.13.1 Business Overview
2.13.2 Macular Edema Therapeutics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Ampio Pharmaceuticals Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.14 Araim Pharmaceuticals
2.14.1 Business Overview
2.14.2 Macular Edema Therapeutics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Araim Pharmaceuticals Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.15 Astellas Pharma
2.15.1 Business Overview
2.15.2 Macular Edema Therapeutics Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Astellas Pharma Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Macular Edema Therapeutics Market Competition, by Players
3.1 Global Macular Edema Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Macular Edema Therapeutics Players Market Share
3.2.2 Top 10 Macular Edema Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Macular Edema Therapeutics Market Size by Regions
4.1 Global Macular Edema Therapeutics Revenue and Market Share by Regions
4.2 North America Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
5 North America Macular Edema Therapeutics Revenue by Countries
5.1 North America Macular Edema Therapeutics Revenue by Countries (2013-2018)
5.2 USA Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe Macular Edema Therapeutics Revenue by Countries
6.1 Europe Macular Edema Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Macular Edema Therapeutics Revenue by Countries
7.1 Asia-Pacific Macular Edema Therapeutics Revenue by Countries (2013-2018)
7.2 China Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
8 South America Macular Edema Therapeutics Revenue by Countries
8.1 South America Macular Edema Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Macular Edema Therapeutics by Countries
9.1 Middle East and Africa Macular Edema Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Macular Edema Therapeutics Revenue and Growth Rate (2013-2018)
10 Global Macular Edema Therapeutics Market Segment by Type
10.1 Global Macular Edema Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Macular Edema Therapeutics Market Forecast by Type (2018-2023)
10.3 Laser Treatment Revenue Growth Rate (2013-2023)
10.4 Anti-VEGF Injection Revenue Growth Rate (2013-2023)
10.5 Anti-Inflammatory Treatment Revenue Growth Rate (2013-2023)
10.6 Vitrectomy Revenue Growth Rate (2013-2023)
11 Global Macular Edema Therapeutics Market Segment by Application
11.1 Global Macular Edema Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Macular Edema Therapeutics Market Forecast by Application (2018-2023)
11.3 Cystoid Macular Edema (CME) Revenue Growth (2013-2018)
11.4 Diabetic Macular Edema(DME) Revenue Growth (2013-2018)
12 Global Macular Edema Therapeutics Market Size Forecast (2018-2023)
12.1 Global Macular Edema Therapeutics Market Size Forecast (2018-2023)
12.2 Global Macular Edema Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Macular Edema Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Macular Edema Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Macular Edema Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Macular Edema Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Macular Edema Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Macular Edema Therapeutics Picture
Table Product Specifications of Macular Edema Therapeutics
Table Global Macular Edema Therapeutics and Revenue (Million USD) Marke
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
